Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists

被引：8

作者：

Biggadike, Keith ^{[1
]}

Caivano, Matilde ^{[1
]}

Clackers, Margaret ^{[1
]}

Coe, Diane M. ^{[1
]}

Hardy, George W. ^{[1
]}

Humphreys, Davina ^{[1
]}

Jones, Haydn T. ^{[1
]}

House, David ^{[1
]}

Miles-Williams, Annette ^{[1
]}

Skone, Philip A. ^{[1
]}

Uings, Iain ^{[1
]}

Weller, Vicki ^{[1
]}

McLay, Iain M. ^{[1
]}

Macdonald, Simon J. F. ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Resp CEDD, Med Res Ctr, Stevenage SG1 2NY, Herts, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 16期

关键词：

Glucocorticoid; Agonist; Non-steroidal; Tractable; MODULATORS; DISCOVERY; FUROATE;

D O I：

10.1016/j.bmcl.2009.06.020

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Starting from a non-steroidal glucocorticoid agonist aryl pyrazole derivative, the NF kappa B agonist activity was optimised in an iterative process from pIC(50) 7.5 (for 7), to pIC(50) 10.1 (for 38E1). An explanation for the SAR observed based is presented along with a proposed docking of 38E1 into the active site of the glucocorticoid receptor. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4846 / 4850

页数：5

共 50 条

[31] Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents
Shah, Kiran
Patel, Dipam
Jadav, Pradip
Sheikh, Mubeen
Sairam, Kalapatapu V. V. M.
Joharapurkar, Amit
Jain, Mukul R.
Bahekar, Rajesh
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (18) : 5857 - 5862
[32] Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice
Nie, Ruifang
Lu, Jian
Xu, Rui
Yang, Juanzhen
Shen, Xingyi
Ouyang, Xingnan
Zhu, Danyang
Huang, Yujie
Zhao, Tong
Zhao, Xuejian
Lu, Yin
Qian, Minyi
Wang, Jiaying
Shen, Xu
[J]. AGING CELL, 2022, 21 (03)
[33] Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate
Berger, Markus
May, Ekkehard
Rehwinkel, Hartmut
Schaecke, Heike
Neuhaus, Roland
Rottmann, Antje
Zollner, Thomas M.
Jaroch, Stefan
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (16)
[34] Non-steroidal steroid receptor modulators
Buijsman, RC
Hermkens, PHH
van Rijn, RD
Stock, HT
Teerhuis, NM
[J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (09) : 1017 - 1075
[35] Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy
Mohler, Michael L.
He, Yali
Wu, Zhongzhi
Hong, Seoung-Soo
Miller, Duane D.
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (01) : 59 - 81
[36] Non-steroidal progesterone receptor modulators
Zhang, PW
Fensome, A
Wrobel, J
Winneker, R
Zhang, ZM
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (12) : 1839 - 1847
[37] Non-steroidal steroid receptor modulators
Hermekns, PHH
Kamp, S
Lusher, S
Veeneman, GH
[J]. IDRUGS, 2006, 9 (07) : 488 - 494
[38] Non-steroidal mineralocorticoid receptor antagonists
Meyers, Marvin J.
Hu, Xiao
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (01) : 17 - 23
[39] Fluorescent benzofuran histamine H3 receptor antagonists with sub-nanomolar potency
Cowart, M
Gfesser, GA
Bhatia, K
Esser, R
Sun, M
Miller, TR
Krueger, K
Witte, D
Esbenshade, TA
Hancock, AA
[J]. INFLAMMATION RESEARCH, 2006, 55 (Suppl 1) : S47 - S48
[40] Fluorescent benzofuran histamine H3 receptor antagonists with sub-nanomolar potency
M. Cowart
G. A. Gfesser
K. Bhatia
R. Esser
M. Sun
T. R. Miller
K. Krueger
D. Witte
T. A. Esbenshade
A. A. Hancock
[J]. Inflammation Research, 2006, 55 : S47 - S48

← 1 2 3 4 5 →